Latest Ratios: P/E Ratio 13.3x · EV/EBITDA 7.6x · ROE 17.2%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $784M | $738M | $1.1B | $1.4B | $840M | $1.0B | $953M | $913M | $866M | $714M | $483M |
| Enterprise Value | $885M | $840M | $1.2B | $1.4B | $893M | $1.0B | $1.0B | $940M | $933M | $771M | $526M |
| P/E Ratio → | 13.33 | 12.52 | 18.82 | 22.10 | 13.60 | 17.10 | 17.62 | 23.15 | 26.73 | 19.74 | 15.91 |
| P/S Ratio | 0.71 | 0.67 | 1.06 | 1.39 | 0.88 | 1.19 | 1.08 | 1.04 | 0.97 | 0.84 | 0.51 |
| P/B Ratio | 2.18 | 2.05 | 3.51 | 4.76 | 3.01 | 4.21 | 4.00 | 3.59 | 3.57 | 3.03 | 1.92 |
| P/FCF | — | — | 15.44 | 13.37 | 454.29 | 12.85 | 19.62 | 13.35 | 16.37 | 17.08 | 6.51 |
| P/OCF | 25.66 | 24.17 | 11.14 | 11.15 | 42.87 | 9.76 | 14.98 | 10.94 | 13.09 | 13.55 | 5.41 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.76 | 1.11 | 1.40 | 0.93 | 1.22 | 1.14 | 1.07 | 1.05 | 0.91 | 0.55 |
| EV / EBITDA | 7.62 | 7.23 | 10.60 | 12.46 | 8.33 | 10.12 | 10.40 | 13.16 | 13.04 | 10.43 | 7.74 |
| EV / EBIT | 10.45 | 10.31 | 14.37 | 16.00 | 10.68 | 12.89 | 13.43 | 16.94 | 17.66 | 13.51 | 10.53 |
| EV / FCF | — | — | 16.15 | 13.48 | 482.53 | 13.18 | 20.66 | 13.75 | 17.62 | 18.45 | 7.08 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 18.4% | 18.4% | 20.1% | 21.2% | 20.9% | 21.5% | 20.0% | 18.1% | 15.6% | 16.8% | 14.4% |
| Operating Margin | 7.7% | 7.7% | 8.0% | 9.0% | 9.1% | 9.9% | 8.9% | 6.2% | 6.3% | 6.9% | 5.4% |
| Net Profit Margin | 5.3% | 5.3% | 5.6% | 6.3% | 6.5% | 7.0% | 6.1% | 4.5% | 3.6% | 4.3% | 3.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 17.2% | 17.2% | 19.6% | 22.0% | 23.7% | 24.9% | 22.0% | 15.9% | 13.6% | 14.8% | 12.3% |
| ROA | 10.6% | 10.6% | 12.8% | 14.4% | 14.6% | 14.8% | 13.5% | 9.8% | 8.0% | 9.2% | 7.4% |
| ROIC | 15.2% | 15.2% | 18.8% | 21.3% | 21.9% | 22.9% | 20.7% | 13.8% | 14.0% | 14.9% | 12.2% |
| ROCE | 20.4% | 20.4% | 23.4% | 27.2% | 28.1% | 28.7% | 26.1% | 17.9% | 19.1% | 19.6% | 16.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.28 | 0.28 | 0.16 | 0.04 | 0.19 | 0.11 | 0.22 | 0.11 | 0.28 | 0.25 | 0.18 |
| Debt / EBITDA | 0.88 | 0.88 | 0.47 | 0.11 | 0.49 | 0.26 | 0.54 | 0.40 | 0.95 | 0.80 | 0.66 |
| Net Debt / Equity | — | 0.28 | 0.16 | 0.04 | 0.19 | 0.11 | 0.21 | 0.11 | 0.27 | 0.24 | 0.17 |
| Net Debt / EBITDA | 0.87 | 0.87 | 0.47 | 0.10 | 0.49 | 0.25 | 0.52 | 0.38 | 0.93 | 0.77 | 0.63 |
| Debt / FCF | — | — | 0.72 | 0.10 | 28.24 | 0.33 | 1.04 | 0.40 | 1.25 | 1.37 | 0.58 |
| Interest Coverage | 22.92 | 22.92 | 32.36 | 40.53 | 43.53 | 56.39 | 37.26 | 18.13 | 15.25 | 19.60 | 14.31 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.22 | 2.22 | 2.34 | 2.97 | 2.31 | 2.25 | 2.13 | 2.69 | 2.11 | 2.31 | 2.91 |
| Quick Ratio | 0.59 | 0.59 | 0.77 | 0.95 | 0.64 | 0.77 | 0.60 | 0.81 | 0.62 | 0.65 | 1.03 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.03 |
| Asset Turnover | — | 1.85 | 2.07 | 2.35 | 2.14 | 2.15 | 2.16 | 2.24 | 2.14 | 2.13 | 2.43 |
| Inventory Turnover | 3.55 | 3.55 | 4.34 | 4.56 | 3.69 | 4.55 | 4.09 | 4.57 | 4.29 | 3.86 | 5.20 |
| Days Sales Outstanding | — | 25.32 | 29.07 | 26.56 | 26.58 | 28.23 | 23.62 | 25.40 | 26.87 | 27.95 | 29.94 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 3.1% | 3.3% | 3.1% | 4.0% | 4.1% | 5.6% | 7.2% | 3.2% | 3.3% | 7.9% | 4.7% |
| Payout Ratio | 41.4% | 41.4% | 57.8% | 87.4% | 55.9% | 96.2% | 127.0% | 73.7% | 87.5% | 156.3% | 74.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 7.5% | 8.0% | 5.3% | 4.5% | 7.4% | 5.8% | 5.7% | 4.3% | 3.7% | 5.1% | 6.3% |
| FCF Yield | — | — | 6.5% | 7.5% | 0.2% | 7.8% | 5.1% | 7.5% | 6.1% | 5.9% | 15.4% |
| Buyback Yield | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | 0.1% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% |
| Total Shareholder Yield | 3.2% | 3.4% | 3.1% | 4.0% | 4.2% | 5.7% | 7.2% | 3.2% | 3.3% | 7.9% | 4.7% |
| Shares Outstanding | — | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $11M | $11M | $11M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying JBSS stock.
John B. Sanfilippo & Son, Inc.'s current P/E ratio is 13.3x. The historical average is 19.5x. This places it at the 44th percentile of its historical range.
John B. Sanfilippo & Son, Inc.'s current EV/EBITDA is 7.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 8.3x.
John B. Sanfilippo & Son, Inc.'s return on equity (ROE) is 17.2%. The historical average is 10.1%.
Based on historical data, John B. Sanfilippo & Son, Inc. is trading at a P/E of 13.3x. This is at the 44th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
John B. Sanfilippo & Son, Inc.'s current dividend yield is 3.10% with a payout ratio of 41.4%.
John B. Sanfilippo & Son, Inc. has 18.4% gross margin and 7.7% operating margin.
John B. Sanfilippo & Son, Inc.'s Debt/EBITDA ratio is 0.9x, indicating low leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Severe Q4 margin collapse
Metrics are mathematically derived from official filings.
Low Multiples Mask Growth Skepticism
JBSS trades at a P/E of 15.06 and EV/EBITDA of 8.50, which appears cheap relative to the peer median, but the PEG ratio of 10.69 suggests the market is pricing in minimal future growth following the recent quarterly earnings miss.
The valuation multiples sit below the averages for peers like Freshpet and Inter Parfums, but the high PEG ratio indicates the market is not rewarding JBSS for earnings growth, likely due to the volatility and recent miss seen in the profitability metrics. This disconnect between low absolute multiples and a high PEG suggests investors are skeptical of the sustainability of margins at current levels. The stock may appear statistically cheap, but its valuation discount likely reflects the commodity-driven earnings risk that peers with stronger brand moats or different cost structures do not face.
Q4 Margin Erosion Signals Operational Stress
The severe compression of gross margin to 15.7% in Q4 2026, as reported in recent financial statements, drove operating margin down to 3.8%, suggesting the company faced significant cost headwinds or pricing pressure that it could not overcome in the quarter.
The quarterly trend shows a dramatic reversal from the stronger 18-19% gross margins seen earlier in the fiscal year, indicating a possible breakdown in the pass-through of commodity costs or an unfavorable mix shift. This level of volatility undermines the investment thesis for a stable consumer staples business and suggests the company's earnings power is more cyclical and less defensible than typically assumed. The operating margin of 3.8% is now dangerously close to breakeven, leaving minimal buffer for any further cost inflation or volume softness.
Declining Efficiency Erodes Investment Returns
Return on invested capital has fallen to 1.7% in Q4 2026, a significant decline from the 4.8% peak in Q3 2025, based on the ratio data, suggesting the substantial recent capital investments are not yet generating commensurate returns.
The trajectory of ROIC, which closely tracks the margin compression, indicates that the expansion in asset base, particularly the 61.4% surge in net PPE, is currently a drag on returns. This pattern is consistent with a company in an investment phase, but the severity of the Q4 drop raises questions about the quality of those investments or the company's ability to utilize new capacity profitably. Without a swift recovery in margins, the rising asset base will continue to dilute returns for shareholders.
Conservative Leverage Provides Strategic Cushion
Despite a recent increase in total debt to $109.3 million, JBSS maintains a debt-to-equity ratio of 0.29 and interest coverage of 27.49x in Q4, according to the balance sheet, indicating a very comfortable ability to service its obligations even during a profit trough.
The extremely low leverage profile is a key differentiator from peers like TreeHouse Foods or The Andersons, providing the company with substantial financial flexibility to weather the current margin pressure without refinancing risk. The high interest coverage ratio, even at the low point of the earnings cycle, suggests that debt service is not a material concern. This balance sheet strength may allow management to pursue opportunistic investments or acquisitions that higher-leveraged competitors cannot, though it also raises the question of whether more leverage could be used to enhance shareholder returns.
Lengthening Cash Cycle Signals Working Capital Strain
The cash conversion cycle stood at 95 days in Q4 2026, an improvement from the prior year but still elevated, and the persistent days inventory outstanding near 96-106 days indicates a significant capital commitment to commodity stocks.
The long inventory holding period exposes the company to substantial valuation risk if commodity prices fall, requiring potential write-downs that would further pressure already thin margins. The relative stability of days sales outstanding around 27-28 days suggests the company has consistent collection practices, but the length of the cycle is largely driven by inventory and, to a lesser extent, payable timing. This working capital profile is a significant cash flow drag and reinforces the view that the business requires continuous, efficient management of physical commodities to generate adequate returns.
The Traps in Standard Peer Comparisons
The most commonly misapplied ratio for JBSS is likely the Price-to-Sales (P/S) multiple, which at 0.80 appears extremely low but fails to account for the company's fundamentally different, lower-margin business model compared to branded peers.
A 0.80 P/S ratio suggests extreme cheapness, but it obscures the reality that JBSS operates in a low-margin, high-volume commodity processing environment where a 15.7% gross margin (Q4) is structurally lower than branded food companies. Investors comparing this P/S to a company like Freshpet (which likely operates at >40% gross margin) are making an apples-to-oranges comparison. The more appropriate metric is EV/EBITDA, which normalizes for capital structure, or a cyclically-adjusted P/E that accounts for the commodity price sensitivity of earnings. Without this adjustment, the stock may appear perpetually undervalued relative to its actual earning power and risk profile.